Cancer

August 2, 2012

Proteins may point way to new prostate cancer drug targets

Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.

By VUMC News and Communications
July 26, 2012

Study finds mutation in melanoma sensitive to drug

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation.

By VUMC News and Communications
July 26, 2012

Photo: Tickled Pink

By VUMC News and Communications
July 24, 2012

Proteins guard against cancer spread

Targeting immune system proteins may keep prostate cancer from spreading to bone.

By VUMC News and Communications
Vitamin E
July 20, 2012

High consumption of vitamin E may lower liver cancer risk

By VUMC News and Communications
July 19, 2012

VICC adds colon cancer to gene mutation testing

Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer.

By VUMC News and Communications
July 18, 2012

VU study finds stress fuels breast cancer metastasis to bone

Stress can promote breast cancer cell colonization of bone, Vanderbilt Center for Bone Biology investigators have discovered.
By Leigh MacMillan
June 11, 2012

Vanderbilt identifies genes linked to breast cancer chemo resistance

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
By VUMC News and Communications
April 26, 2012

New drug mutes more melanomas

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
By VUMC News and Communications
April 18, 2012

Free head and neck cancer screening April 27

By VUMC News and Communications
April 13, 2012

Wilms’ tumors differ in developing nations

In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations.
By VUMC News and Communications
April 6, 2012

Factor sensitizes cancer to radiation

Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy.
By VUMC News and Communications
April 6, 2012

Gut germs govern growth

Treating H. pylori infection in children may help their growth rebound, a recent study suggests.
By VUMC News and Communications